Literature DB >> 12569614

Utilization of special education services and educational attainment among long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

Pauline A Mitby1, Leslie L Robison, John A Whitton, Michael A Zevon, Iris C Gibbs, Jean M Tersak, Anna T Meadows, Marilyn Stovall, Lonnie K Zeltzer, Ann C Mertens.   

Abstract

BACKGROUND: The objective of the current report was to compare the self-reported rates of special education (SE) and educational attainment among specific groups of childhood cancer survivors and a random sample of sibling controls.
METHODS: The Childhood Cancer Survivor Study is a retrospective cohort of individuals who were diagnosed with a cancer in childhood and survived at least 5 years postdiagnosis. This analysis includes 12,430 survivors and 3410 full siblings. Reported use of SE services and educational attainment were analyzed within subgroups defined by type of cancer, age at diagnosis, and type of treatment.
RESULTS: The use of SE services was reported in 23% of survivors and 8% of siblings, with the greatest differences observed among survivors who were diagnosed before age 6 years, most notably survivors of central nervous system (CNS) tumors (odds ratio [OR], 18.8; 95% confidence interval [95%CI], 15.01-23.49), leukemia (OR, 4.4; 95%CI, 3.75-5.16), and Hodgkin disease (OR, 4.4; 95%CI, 2.64-7.24). It was found that intrathecal methotrexate (IT MTX) and cranial radiation (CRT), administered alone or in combination, significantly increased the likelihood that a survivor would use SE (IT MTX only: OR, 1.3; 95%CI, 1.09-1.78; CRT only: OR, 7.2; 95%CI, 6.14-8.39; IT MTX and CRT combined: OR, 2.6; 95%CI, 2.30-2.95). A positive dose response was identified between higher doses of CRT and use of SE. It was determined that survivors of leukemia (OR, 1.6; 95%CI, 1.23-2.16), CNS tumors (OR, 2.7; 95%CI, 1.92-3.81), non-Hodgkin lymphoma (OR, 1.8; 95%CI, 1.15-2.78), and neuroblastoma (OR, 1.7; 95%CI, 1.14-2.61) were significantly less likely to finish high school compared with siblings; however, when survivors received SE services, risk estimates approximated those of the sibling SE population.
CONCLUSIONS: Children who are diagnosed with cancer should be followed closely during and after treatment to identify early signs of learning disabilities and to maximize intervention strategies for the successful completion of scholastic goals. Copyright 2003 American Cancer Society

Entities:  

Mesh:

Year:  2003        PMID: 12569614     DOI: 10.1002/cncr.11117

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.921


  92 in total

1.  Population-based exploration of academic achievement outcomes in pediatric acute lymphoblastic leukemia survivors.

Authors:  Lyndsay A Harshman; Sheila Barron; Anna M Button; Brian J Smith; Brian K Link; Charles F Lynch; Natalie L Denburg
Journal:  J Pediatr Psychol       Date:  2012-01-23

2.  Parent and teacher ratings of attention during a year-long methylphenidate trial in children treated for cancer.

Authors:  Kelli L Netson; Heather M Conklin; Jason M Ashford; Lisa S Kahalley; Shengie Wu; Xiaoping Xiong
Journal:  J Pediatr Psychol       Date:  2010-11-19

3.  The effects of response bias on self-reported quality of life among childhood cancer survivors.

Authors:  Tara E O'Leary; Lisa Diller; Christopher J Recklitis
Journal:  Qual Life Res       Date:  2007-07-11       Impact factor: 4.147

4.  Cognitive, behaviour, and academic functioning in adolescent and young adult survivors of childhood acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study.

Authors:  Lisa M Jacola; Kim Edelstein; Wei Liu; Ching-Hon Pui; Robert Hayashi; Nina S Kadan-Lottick; Deokumar Srivastava; Tara Henderson; Wendy Leisenring; Leslie L Robison; Gregory T Armstrong; Kevin R Krull
Journal:  Lancet Psychiatry       Date:  2016-09-14       Impact factor: 27.083

5.  Social-ecological predictors of school functioning in Hispanic children treated for cancer with central nervous system-directed therapies.

Authors:  Sunita K Patel; Christopher Johansen; Abigail Onderwyzer Gold; Nicole Delgado; Sandra Xu; Jessica Dennis
Journal:  Pediatr Blood Cancer       Date:  2020-07-31       Impact factor: 3.167

6.  Neurocognitive Consequences of Childhood Leukemia and Its Treatment.

Authors:  Ayşe Bozkurt Turhan; S Tülin Fidan; Coşkun Yarar; E Nazlı Sakallı; Zeynep Canan Özdemir; Özcan Bör
Journal:  Indian J Hematol Blood Transfus       Date:  2017-07-04       Impact factor: 0.900

7.  Cognitive Performance, Aerobic Fitness, Motor Proficiency, and Brain Function Among Children Newly Diagnosed With Craniopharyngioma.

Authors:  Heather M Conklin; Kirsten K Ness; Jason M Ashford; Matthew A Scoggins; Robert J Ogg; Yuanyuan Han; Yimei Li; Julie A Bradley; Frederick A Boop; Thomas E Merchant
Journal:  J Int Neuropsychol Soc       Date:  2019-04       Impact factor: 2.892

8.  Annual Economic Burden of Productivity Losses Among Adult Survivors of Childhood Cancers.

Authors:  Gery P Guy; Zahava Berkowitz; Donatus U Ekwueme; Sun Hee Rim; K Robin Yabroff
Journal:  Pediatrics       Date:  2016-11       Impact factor: 7.124

9.  Poor adherence to dietary guidelines among adult survivors of childhood acute lymphoblastic leukemia.

Authors:  Kim Robien; Kirsten K Ness; Lisa M Klesges; K Scott Baker; James G Gurney
Journal:  J Pediatr Hematol Oncol       Date:  2008-11       Impact factor: 1.289

10.  Exploring family management of childhood brain tumor survivors.

Authors:  Janet A Deatrick; Erin K Mullaney; Kim Mooney-Doyle
Journal:  J Pediatr Oncol Nurs       Date:  2009 Sep-Oct       Impact factor: 1.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.